Jee-Hyun Kim

A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence

Jee-Hyun Kim, Kathryn O’Brien, Ritu Sharma et al. · Proceedings of the National Academy of Sciences · 2013 · 142 citations · Full text

Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells

Ju‐Hee Lee, Jung‐Hyun Park, Yeonjoo Jung et al. · Molecular Cancer Therapeutics · 2006 · 97 citations

Histone Deacetylase Inhibitor, Molecular Regulation, 5-Fluorouracil Cytotoxicity +24

CPR or DNR? End-of-life decision in Korean cancer patients: a single center’s experience

Do‐Youn Oh, Jee-Hyun Kim, Dong-Wan Kim et al. · Supportive Care in Cancer · 2005 · 85 citations

Palliative Care, End-of-life Care, Medicine +9

Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience

Moon Ju Jang, So Young Chong, In Ho Kim et al. · International Journal of Hematology · 2011 · 44 citations · Full text

Thrombopoiesis, Thrombosis, Adamts13 Deficiency +8

Epstein-Barr Virus-Positivity in Tumor has no Correlation with the Clinical Outcomes of Patients with Angioimmunoblastic T-cell Lymphoma

Yuna Lee, Keun‐Wook Lee, Jee-Hyun Kim et al. · The Korean Journal of Internal Medicine · 2008 · 18 citations · Full text